http://editage.wichtig.com is a partnership between Wichtig Publishing and Editage. Together, we offer pre-submission services to authors who aim to publish their research in journals such as the International Journal of Artificial Organs, European Journal of Ophthalmology, HIP International, Journal of Vascular Access, International Journal of Biological Markers and Journal of Scleroderma and Related Disorders. Learn more at www.wichtig.com. Learn more at www.editage.com.
Wichtig International is an independent STM publisher of journals in the fields of clinical medicine and bioengineering. Specializing in areas such as nephrology, oncology, ophthalmology, orthopedics, gynecology, rheumatology, urology, and biomaterials, titles include The International Journal of Artificial Organs, the European Journal of Ophthalmology, HIP International, The Journal of Vascular Access, The International Journal of Biological Markers and the Journal of Scleroderma and Related Disorders amongst others.
Editage is a leading provider of specialist language solutions, including academic editing, publication support services, academic translation, author education, and medical communication. Since 2002, Editage has helped more than 207,100 authors from 172 countries achieve their communication goals. Known for its quality guarantee and an accomplished editing team that comprises editors specializing in more than 1,200 subject areas, it offers a range of service levels and turnaround times to help authors with different requirements.
Please note that use of this service is not mandatory for publication in Wichtig journals nor does it guarantee peer review or acceptance. You are not obliged to submit your manuscript to one of our journals if you choose to use any of these services. All services are provided solely by Editage.